跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ICATIBANTO FRESENIUS 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Approved
STANDARD
ICATIBANTO FRESENIUS 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Fresenius Kabi España, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 19, 2022
Approval ID
ee3bf0c336d28d6b
Company
Fresenius Kabi España, S.A.U.
Type
Standard
Approval Details
Approval Id
ee3bf0c336d28d6b
Drug Cima Aemps Name
ICATIBANTO FRESENIUS 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Register Number
86865
Holder Company Name
Fresenius Kabi España, S.A.U.
Marketing Company Name
Fresenius Kabi España, S.A.U.
Authorization Date
2022-04-19
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
30 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Fresenius Kabi España, S.A.U.
Active Ingredients
ICATIBANTO ACETATO
36 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 19, 2022
Approval ID
ee3bf0c336d28d6b
Type
Standard
Back to CIMA-AEMPS Approvals
ICATIBANTO FRESENIUS 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG - CIMA-AEMPS Drug Approval Details
